Author name: ArthVed 9X Editor

Introduction: When Wars Hit Your Portfolio The ongoing military escalation involving the United States, Israel, and Iran has shaken global financial markets, and India is feeling the tremors all the way on Dalal Street. If you have been watching your Sensex or Nifty portfolio dip in recent weeks, you are not imagining it. Geopolitical storms in the Middle East have a very direct and measurable impact on India’s economy, and 2026 is proving to be no exception.In this detailed blog, we break down exactly how this conflict is affecting Indian markets, which sectors are hurting most, which ones are quietly gaining, what the rupee and inflation picture looks like, and most importantly, when investors can realistically expect a recovery. 📌 KEY STAT: Over ₹11 lakh crore was wiped from Indian market capitalisation in the immediate aftermath of the US–Israel strikes on Iran. The Sensex fell more than 1,000 points in a single session. Why Does a Middle East War Affect Indian Markets? A. Crude Oil — India’s Biggest Vulnerability India imports approximately 88–89% of its crude oil requirements, spending around $137 billion annually on crude oil imports, nearly 15% of the country’s total import bill. Any disruption in the Middle East, which controls a major share of global oil supply, immediately raises the cost of energy for India. The Strait of Hormuz, a narrow waterway through which roughly 30% of the world’s seaborne oil passes, runs through the conflict zone. Fears of its closure have already pushed Brent crude up by 9–10%, from around $70 to nearly $80 per barrel. If a blockade materialises, analysts warn that oil could surge to $120 per barrel. 💡 Did You Know: Every $10 rise in crude oil prices slows India’s GDP growth by 0.3–0.4% and pushes Consumer Price Inflation (CPI) up by approximately 0.4%. B. Foreign Portfolio Investor (FPI) Sell-Off Foreign Portfolio Investors own nearly 20% of Indian equities. During periods of global geopolitical tension, these investors instinctively move toward safe-haven assets — US Treasury bonds, gold, and the US dollar, pulling money out of emerging markets like India. This FPI outflow creates selling pressure on Indian stocks and weakens the rupee simultaneously. C. Global Risk Sentiment & Supply Chain Disruptions Beyond oil, the conflict disrupts shipping routes across the Gulf and West Asia. Indian exporters, especially in pharmaceuticals, chemicals, and engineering goods, face higher freight costs, insurance premiums, and order delays. This squeezes corporate margins and weighs on broader market sentiment. 2. How Has the Indian Market Reacted So Far? Indian benchmark indices have witnessed significant selling pressure since tensions escalated: Markets have reacted not just to the actual conflict but to the fear of prolonged disruption. Investor sentiment is extremely sensitive to geopolitical headlines, and this uncertainty creates volatility beyond what the underlying economic impact alone would justify. 3. Sector-by-Sector Impact on Indian Markets 🔴 Sectors Under Pressure Aviation & Travel: Airlines are among the hardest hit. Aviation Turbine Fuel (ATF) is a crude oil derivative, and with fuel costs rising sharply, airline margins are being severely compressed. Aviation stocks have seen declines of 8–10%. Hotel companies have also reported booking cancellations due to flight disruptions. Oil Marketing Companies (OMCs): OMCs such as HPCL, BPCL, and IOC face a classic squeeze; they buy crude at global prices but often cannot pass the full increase to consumers immediately due to price regulation. This creates margin compression and negative investor sentiment. Auto & Tyre Manufacturers: Higher crude oil means higher input costs for rubber and petrochemical derivatives used in tyres. Export-heavy auto players also face rising shipping costs. Domestic auto volumes remain healthy, which limits downside, but near-term margin pressure is real. Chemicals & Pharmaceuticals: Rising Gulf shipping costs are pushing up raw material prices and logistics costs. West Asia and North Africa represent about 5.7% of India’s pharmaceutical exports (approximately $1.75 billion in FY25), creating near-term challenges. Engineering & EPC Companies: Firms with significant order books from Gulf countries, Saudi Arabia, UAE, and Kuwait face risks of project delays if the regional situation deteriorates further. Consumer Staples & FMCG: Higher input costs tied to crude oil and weakening consumer sentiment create headwinds for FMCG companies, though the impact is more gradual. 🟢 Sectors Likely to Benefit Defence: Stocks like HAL (Hindustan Aeronautics Limited) and Bharat Electronics Limited (BEL) have historically rallied during geopolitical tensions. During the April 2024 Iran–Israel escalation, HAL’s stock rose 12%. Long-term, the conflict supports India’s domestic defence manufacturing push. Gold & Silver: Safe-haven demand for precious metals spikes during geopolitical uncertainty. Gold prices have already risen about 3%, and MCX benefits from higher trading volumes in bullion and energy. Upstream Oil Producers: Domestic oil exploration companies benefit from higher global crude prices as their asset realisation increases. IT Sector (Mixed): A stronger US dollar during global risk-off periods benefits Indian IT exporters in rupee terms. However, if global growth concerns mount, order inflows could slow, making this a mixed picture overall. 4. Impact on the Indian Rupee and Inflation The rupee has come under meaningful pressure. A combination of FPI outflows, rising import bills (especially crude), and a global flight to the US dollar has pushed the currency weaker. A weaker rupee is inflationary by nature; it makes every import more expensive, including crude oil, edible oils, electronics, and capital goods. If crude prices stay elevated for an extended period, the Reserve Bank of India (RBI) may face pressure to keep interest rates higher for longer, which would weigh on rate-sensitive sectors, including banking, real estate, and consumer finance. ⚠️ Macro Risk: If oil prices sustain above $100/barrel, India’s current account deficit could widen significantly, GDP growth could slow by 0.4–0.5%, and CPI inflation could re-accelerate forcing RBI to delay its rate-cutting cycle. 5. Historical Precedents: What Past Crises Tell Us India’s markets have weathered multiple geopolitical shocks before. History offers a reassuring roadmap: The consistent pattern across these crises: sharp initial panic, heightened volatility for weeks, followed by stabilisation once geopolitical clarity emerges. 6. When Can

Why Nifty IT Stocks Are Falling – Explained (2026 Analysis) The Nifty IT index, representing India’s leading information technology companies like TCS, Infosys, Wipro, HCL Tech, and Tech Mahindra, has recently experienced sharp declines, with multiple sessions of losses and several heavyweight stocks slipping to multi-month lows. This has raised alarm among investors and market watchers. In this blog, we break down the top reasons behind this downturn, what it means for the sector, and what investors should watch next. 1. AI-Driven Disruption Fears One of the largest triggers for the current sell-off is the fear that artificial intelligence (AI) will disrupt the traditional business model of Indian IT companies. Firms in the sector have historically relied on a labour-intensive, outsourcing-based model, billing clients for manpower deployed across projects. Recent developments – such as AI tools capable of automating tasks across legal, marketing, data processing, and operations have heightened investor concerns that billable hours and staffing demand may shrink, undermining future revenue growth. 2. Fading U.S. Rate Cut Expectations Strong economic data out of the United States, including robust job growth, has reduced market expectations for near-term interest rate cuts by the U.S. Federal Reserve. Higher or sustained interest rates tend to dampen global growth prospects, leading to slower tech spending by businesses. As Indian IT firms derive a significant portion of revenue from U.S. clients, this macroeconomic shift has weighed heavily on valuations. 3. Global Tech Market Weakness Indian IT stocks are not moving in isolation. Broader declines in global technology markets, including sell-offs in major indices like the Nasdaq and weakness in ADRs of Infosys and Wipro, have spilled over into Indian equities. These linkages reflect rising risk aversion among investors and momentum selling in technology sectors worldwide. 4. Profit Taking and Valuation Corrections After years of strong performance, many IT stocks were trading at relatively high valuations. When market sentiment shifts especially on fears of slower growth – profit booking can accelerate downturns, driving prices lower even without negative company-specific news. 5. Structural Business Model Challenges Beyond AI and macro factors, analysts point to deeper concerns about the traditional IT services model. As enterprises increasingly demand outcome-based pricing and digital transformation services instead of routine outsourcing work, Indian IT players may need to reinvent their service offerings and adapt their revenue mix. 6. Sector Rotation & Foreign Investor Outflows At times of volatility, investors often rotate capital into sectors perceived as safer or more defensive, such as banking or consumer goods, away from large tech exposures. Additionally, foreign institutional investors have been reducing exposure to risk assets, contributing to downward pressure on IT equities. What This Means for Investors The recent fall in the Nifty IT index reflects a mixture of structural disruption fears, macroeconomic shifts, and changing investor sentiment. While AI holds promise for long-term technological transformation, its current market interpretation is skewed toward threat rather than opportunity, especially for legacy outsourcing models. Understanding these forces can help investors navigate volatility and position themselves for future growth opportunities.

In a shocking move, the United States has announced a 100% tariff on pharmaceutical imports, citing national security concerns and rising domestic production costs. While this may sound like a distant headline, its ripples are expected to be felt globally—especially in India’s pharma sector, which has long been a key supplier to the US market. Immediate Impact on Pharma Companies US tariffs of this magnitude will directly hit export revenues for pharmaceutical companies that rely heavily on the American market. Firms with significant sales to the US may face: Companies that are agile and have diversified markets outside the US may weather the storm better, but the short-term impact is likely to be negative across the board. What This Means for Indian Pharma Companies India is one of the largest exporters of generic drugs to the US. Giants like Sun Pharma, Dr. Reddy’s, Cipla, and Lupin could see a direct hit. Analysts suggest: However, some positive trends may emerge: Indian Pharma Index: The Market Reaction The Nifty Pharma Index, which tracks the performance of major pharmaceutical companies, is likely to face immediate downward pressure. Key points to watch: Investor Takeaway For investors tracking the Nifty Pharma Index or individual pharma stocks, the US tariff is a wake-up call: While this move may create short-term turbulence, long-term growth prospects for Indian pharma remain intact, driven by rising domestic demand, innovation, and exports to other regions. Smart investors will use this volatility to identify resilient stocks rather than panic sell. ArthVed9X Insight:The market reacts first, but fundamentals win later. Keep watching pharma companies’ US exposure, diversification strategy, and domestic growth plans to make informed decisions during this tariff-driven storm.